北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第三临床医学院  > 骨科  > 期刊论文
学科主题: 临床医学
题名:
Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo
作者: Chen, Changbao1; Zhou, Hua1; Xu, Lanjun2,3; Xu, Dong2,3; Wang, Ying2,3; Zhang, Yingmei2,3; Liu, Xiaoguang1; Liu, Zhongjun1; Ma, Dalong2,3; Ma, Qingjun1; Chen, Yingyu2,3
关键词: PDCD5 ; Apoptosis ; Chondrosarcoma ; Cisplatin ; Antitumor activity
刊名: APOPTOSIS
发表日期: 2010-07-01
DOI: 10.1007/s10495-010-0489-5
卷: 15, 期:7, 页:805-813
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Biochemistry & Molecular Biology ; Cell Biology
研究领域[WOS]: Biochemistry & Molecular Biology ; Cell Biology
关键词[WOS]: GENE-EXPRESSION PROFILES ; INDUCED APOPTOSIS ; TUMOR-CELLS ; MYELOID-LEUKEMIA ; CANCER ; DEATH ; BCL-2 ; OVEREXPRESSION ; OSTEOSARCOMA ; PROGRESSION
英文摘要:

Clinical management of chondrosarcoma remains a challenging problem, largely due to the toxicity and resistance of this tumor to conventional chemotherapy. Programmed Cell Death 5 (PDCD5) is a protein that accelerates apoptosis in different cell types in response to various stimuli, and has been shown to be down-regulated in many cancer tissues. In this study, mRNA and protein levels of PDCD5 were found to be up-regulated in cisplatin-treated SW1353 chondrosarcoma cells compared with untreated cells. Recombinant human PDCD5 (rhPDCD5) was also shown to sensitize chondrosarcoma cells to cisplatin-based chemotherapy, with inhibition of cell growth and apoptosis detected both in vitro and in vivo. Increased expression of Bax and decreased expression of Bcl-2 were also observed, along with release of cytochrome c from mitochondria into the cytosol. Additionally, cleavage of caspase-9 and caspase-3, as well as the cleavage of poly (ADP-ribose) polymerase (PARP), were detected, suggesting that sensitization of chondrosarcoma cells involves the intrinsic mitochondrial apoptosis pathway. In vivo, the treatment of a xenograft model of chondrosarcoma with rhPDCD5 and cisplatin significantly inhibited tumor cell proliferation and induced apoptosis compared to treatment with cisplatin alone. Overall, these data provide a theoretical basis for the administration of rhPDCD5 and cisplatin for the treatment of patients with chondrosarcoma.

语种: 英语
所属项目编号: 30871263 ; 30571870 ; 2009ZX09102-242 ; 2006AA02A305
项目资助者: National Natural Sciences Foundation of China ; National Key New Drug Creation Program of China ; National High Technology Research and Development Program of China
WOS记录号: WOS:000279190700005
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/62096
Appears in Collections:北京大学第三临床医学院_骨科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Hosp 3, Dept Orthopaed, Beijing 100191, Peoples R China
2.Peking Univ, Ctr Human Dis Genom, Beijing 100191, Peoples R China
3.Peking Univ, Sch Basic Med Sci, Lab Med Immunol, Beijing 100191, Peoples R China

Recommended Citation:
Chen, Changbao,Zhou, Hua,Xu, Lanjun,et al. Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo[J]. APOPTOSIS,2010,15(7):805-813.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Chen, Changbao]'s Articles
[Zhou, Hua]'s Articles
[Xu, Lanjun]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Chen, Changbao]‘s Articles
[Zhou, Hua]‘s Articles
[Xu, Lanjun]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace